A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Venglustat

Pharmaceutical form:Tablet-Route of administration:Oral

DRUG

Venglustat

Pharmaceutical form:Hard Capsule-Route of administration:Oral

Trial Locations (2)

33014

Clinical Pharmacology of Miami Site Number : 8400001, Miami

55144

Prism Research Site Number : 8400002, Saint Paul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY